We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

102 hedge funds and large institutions have $311M invested in iShares US Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 4

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

20% more capital invested

Capital invested by funds: $259M → $311M (+$52.1M)

19% more funds holding

Funds holding: 86 → 102 (+16)

6.69% more ownership

Funds ownership: 105.34% → 112.03% (+6.7%)

3% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 30

Holders
102
Holders Change
+16
Holders Change %
+18.6%
% of All Funds
2.72%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
31
Reduced
30
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
Brookstone Capital Management
Illinois
+$15.1M
2
BWM
Braver Wealth Management
Massachusetts
+$11.9M
3
Citadel Advisors
Citadel Advisors
Florida
+$4.2M
4
Wells Fargo
Wells Fargo
California
+$3.46M
5
SG Americas Securities
SG Americas Securities
New York
+$2.83M

Top Sellers

1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$12.1M
2
RJA
Raymond James & Associates
Florida
-$2.76M
3
TRCT
Tower Research Capital (TRC)
New York
-$2.6M
4
Bank of America
Bank of America
North Carolina
-$2.3M
5
Morgan Stanley
Morgan Stanley
New York
-$810K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAG
26
Pinnacle Advisory Group
Maryland
$2.23M -$35.1K -720 -2%
PP
27
Patten & Patten
Tennessee
$1.95M -$183K -3,750 -9%
CS
28
Credit Suisse
Switzerland
$1.83M +$23.4K +480 +1%
VFS
29
VSR Financial Services
Kansas
$1.65M +$915K +18,777 +135%
CPC
30
Cookson Peirce & Co
Pennsylvania
$1.65M -$114K -2,340 -7%
CAN
31
Cetera Advisor Networks
California
$1.61M +$229K +4,692 +17%
CFA
32
Cahill Financial Advisors
Minnesota
$1.5M +$30K +615 +2%
DADC
33
D.A. Davidson & Co
Montana
$1.47M -$52.8K -1,083 -4%
Stifel Financial
34
Stifel Financial
Missouri
$1.19M +$48.7K +999 +4%
SPC
35
Sigma Planning Corp
Michigan
$1.15M +$1.11M +22,836 New
TRCT
36
Tower Research Capital (TRC)
New York
$1.1M -$2.6M -53,325 -71%
AMG
37
Asset Management Group
Connecticut
$1.06M +$60.4K +1,239 +6%
KCM
38
Karp Capital Management
California
$1.03M +$993K +20,370 New
CIBC World Market
39
CIBC World Market
Ontario, Canada
$1M -$573K -11,757 -37%
WA
40
WESPAC Advisors
California
$983K -$79.1K -1,623 -8%
PHS
41
Pekin Hardy Strauss
Illinois
$983K +$949K +19,476 New
NES
42
New England Securities
New York
$955K +$239K +4,911 +35%
CLOS
43
Compagnie Lombard Odier SCmA
Switzerland
$930K +$899K +18,444 New
Koshinski Asset Management
44
Koshinski Asset Management
Illinois
$903K +$872K +17,901 New
SAM
45
Stringer Asset Management
Tennessee
$900K +$13.6K +279 +2%
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$883K -$12.1M -247,761 -93%
JP Morgan Chase
47
JP Morgan Chase
New York
$810K +$339K +6,954 +77%
ICOA
48
Investment Centers of America
North Dakota
$765K -$234K -4,803 -24%
LTFS
49
Ladenburg Thalmann Financial Services
Florida
$761K +$384K +7,881 +110%
NPC
50
National Planning Corporation
California
$722K +$14.6K +300 +2%
1
2
3 4 5

IHE Hedge Fund Activity: Q4 2014 in Review

102 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2014, worth a combined $311M — up 20% from $259M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IHE positions and 4 closed out — a net gain of 17 holders — while 31 added to existing stakes and 30 trimmed.

The largest buyer was Brookstone Capital Management, opening a new position worth an estimated $15.1M. The largest seller was Bank of Montreal, cutting an estimated $12.1M.

  • 102 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2014, up from 86 in Q3 2014.
  • Funds reported $311M of iShares US Pharmaceuticals ETF stock for Q4 2014, up 20% quarter-over-quarter.
  • 21 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2014 and 4 closed out, a net change of +17 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2014 was Brookstone Capital Management, an estimated $15.1M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2014 was Bank of Montreal, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2014.